Latest Curex News & Updates

See the latest news and media coverage for Curex. We track all announcements, press releases, and industry mentions in real time, all in one place.

Curex

Online allergy clinic offering at-home immunotherapy

getcurex.com

Headquarters: New York, United States
Founded year: 2019
Company type: Private company
Number of employees: 10–125

Last updated Today

Latest news about Curex

Company announcements

June 22 Curex

Curex explores peptide evidence for allergies

No human trials exist for any peptide in allergic disease; the evidence points to allergen immunotherapy as the effective treatment.

January 2 Curex

Curex summarizes research on sublingual immunotherapy

The post covers history, safety, efficacy, duration, and comparison to injections, citing numerous clinical trials.

19 March 2024 Curex

Curex explains why insurance does not cover allergy drops

Allergy drops lack FDA approval and are costly, leading insurers to deny coverage.

3 January 2024 Curex

Curex explains why allergy drops are not FDA-approved

Allergy drops are sublingual immunotherapy; the FDA hasn't approved them due to lack of standardized dosage, but research supports their effectiveness.

Media coverage

30 October 2024 Yahoo Finance

Curex Introduces a Safer, At-Home Alternative to Food Oral Immunotherapy

Miami, FL, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Curex, the leader in telemedicine allergy immunotherapy treatments, announces the launch of its innovative at-home Sublingual Immunotherapy...

6 April 2021 RAPS

Manhattan firm's "allergy drops" prompt CBER untitled letter

The US Food and Drug Administration's (FDA's) biologics division has delivered an untitled letter to a Manhattan-based firm for marketing sublingual "allergy drops" from its...

6 November 2014 Yahoo Finance

Curex Group And Nasdaq, Inc. Announce Index Development Partnership

New York, NY / ACCESSWIRE / November 4, 2014 / Curex Group and Nasdaq, Inc. (Nasdaq:NDAQ) today announced a new partnership featuring transparent, executable OTC...

23 June 2014 Traders Magazine

TRADERS ON THE MOVE: Fidessa Gets New Global Head of E-Execution, New CEO at Curex

David Polen, Fidessa Group's head of U.S. business development has transitioned to the firm's execution side and was named global head of electronic execution. Polen...

Never miss news about Curex

Track Curex and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.